GSK logo

GSK plc (GSK) Cost of goods sold

annual cost of goods sold:

$12.11B+$826.61M(+7.33%)
December 31, 2024

Summary

  • As of today (August 20, 2025), GSK annual cost of goods sold is $12.11 billion, with the most recent change of +$826.61 million (+7.33%) on December 31, 2024.
  • During the last 3 years, GSK annual cost of goods sold has risen by +$620.64 million (+5.40%).
  • GSK annual cost of goods sold is now -13.97% below its all-time high of $14.08 billion, reached on December 31, 2020.

Performance

GSK Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

quarterly cost of goods sold:

$2.89B+$466.40M(+19.23%)
June 30, 2025

Summary

  • As of today (August 20, 2025), GSK quarterly cost of goods sold is $2.89 billion, with the most recent change of +$466.40 million (+19.23%) on June 30, 2025.
  • Over the past year, GSK quarterly cost of goods sold has increased by +$266.17 million (+10.14%).
  • GSK quarterly cost of goods sold is now -38.05% below its all-time high of $4.67 billion, reached on December 31, 2015.

Performance

GSK quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

TTM cost of goods sold:

$11.60B+$266.17M(+2.35%)
June 30, 2025

Summary

  • As of today (August 20, 2025), GSK TTM cost of goods sold is $11.60 billion, with the most recent change of +$266.17 million (+2.35%) on June 30, 2025.
  • Over the past year, GSK TTM cost of goods sold has increased by +$111.46 million (+0.97%).
  • GSK TTM cost of goods sold is now -22.07% below its all-time high of $14.88 billion, reached on March 31, 2020.

Performance

GSK TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

GSK Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.3%+10.1%+1.0%
3 y3 years+5.4%+7.0%-9.1%
5 y5 years-12.7%-4.4%-21.5%

GSK Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.3%+7.3%-18.3%+24.7%-9.9%+14.4%
5 y5-year-14.0%+7.3%-26.3%+24.7%-21.5%+14.4%
alltimeall time-14.0%+528.9%-38.0%+1015.7%-22.1%+2290.1%

GSK Cost of goods sold History

DateAnnualQuarterlyTTM
Jun 2025
-
$2.89B(+19.2%)
$11.60B(+2.3%)
Mar 2025
-
$2.43B(-25.4%)
$11.33B(-0.3%)
Dec 2024
$12.11B(+7.3%)
$3.25B(+7.4%)
$11.36B(-2.5%)
Sep 2024
-
$3.03B(+15.3%)
$11.65B(+1.4%)
Jun 2024
-
$2.63B(+6.9%)
$11.48B(+2.0%)
Mar 2024
-
$2.46B(-30.6%)
$11.26B(+1.2%)
Dec 2023
$11.28B(-7.1%)
$3.54B(+23.6%)
$11.12B(+9.5%)
Sep 2023
-
$2.86B(+19.2%)
$10.16B(+0.3%)
Jun 2023
-
$2.40B(+3.6%)
$10.13B(-2.9%)
Mar 2023
-
$2.32B(-10.0%)
$10.43B(-11.0%)
Dec 2022
$12.15B(+5.7%)
$2.58B(-9.2%)
$11.72B(-9.0%)
Sep 2022
-
$2.84B(+4.9%)
$12.88B(+1.0%)
Jun 2022
-
$2.70B(-25.1%)
$12.75B(+2.7%)
Mar 2022
-
$3.61B(-3.3%)
$12.41B(+1.9%)
Dec 2021
$11.49B(-18.4%)
$3.73B(+37.4%)
$12.18B(-1.6%)
Sep 2021
-
$2.71B(+14.8%)
$12.38B(-6.1%)
Jun 2021
-
$2.36B(-29.9%)
$13.18B(-4.8%)
Mar 2021
-
$3.37B(-14.1%)
$13.84B(-2.4%)
Dec 2020
$14.08B(+1.5%)
$3.92B(+11.6%)
$14.18B(-1.7%)
Sep 2020
-
$3.52B(+16.2%)
$14.42B(-2.4%)
Jun 2020
-
$3.03B(-18.5%)
$14.77B(-0.7%)
Mar 2020
-
$3.71B(-10.8%)
$14.88B(+4.2%)
Dec 2019
$13.87B(+5.1%)
$4.16B(+7.7%)
$14.28B(+3.1%)
Sep 2019
-
$3.87B(+23.3%)
$13.85B(+3.2%)
Jun 2019
-
$3.13B(+0.6%)
$13.42B(-0.0%)
Mar 2019
-
$3.12B(-16.6%)
$13.43B(-1.6%)
Dec 2018
$13.20B(+1.4%)
$3.74B(+8.8%)
$13.64B(+2.6%)
Sep 2018
-
$3.44B(+9.4%)
$13.30B(-0.3%)
Jun 2018
-
$3.14B(-5.6%)
$13.33B(-1.6%)
Mar 2018
-
$3.33B(-2.0%)
$13.54B(+1.6%)
Dec 2017
$13.01B(+2.3%)
$3.39B(-2.2%)
$13.33B(+2.2%)
Sep 2017
-
$3.47B(+3.5%)
$13.05B(+1.1%)
Jun 2017
-
$3.35B(+7.7%)
$12.91B(+3.4%)
Mar 2017
-
$3.11B(+0.1%)
$12.48B(+1.4%)
Dec 2016
$12.72B(-6.6%)
$3.11B(-6.5%)
$12.32B(-11.2%)
Sep 2016
-
$3.33B(+13.5%)
$13.87B(+1.1%)
Jun 2016
-
$2.93B(-0.5%)
$13.72B(+0.0%)
Mar 2016
-
$2.95B(-36.9%)
$13.72B(+0.8%)
Dec 2015
$13.62B(+11.1%)
$4.67B(+46.9%)
$13.61B(+13.8%)
Sep 2015
-
$3.18B(+8.5%)
$11.96B(+2.3%)
Jun 2015
-
$2.93B(+3.3%)
$11.69B(+0.8%)
Mar 2015
-
$2.84B(-6.1%)
$11.59B(+0.0%)
Dec 2014
$12.26B(-4.5%)
$3.02B(+4.1%)
$11.59B(-6.4%)
Sep 2014
-
$2.90B(+2.5%)
$12.38B(-1.4%)
Jun 2014
-
$2.83B(-0.1%)
$12.55B(-1.0%)
Mar 2014
-
$2.83B(-25.6%)
$12.68B(-1.5%)
Dec 2013
$12.84B(+4.1%)
$3.81B(+24.0%)
$12.87B(+1.6%)
Sep 2013
-
$3.07B(+3.9%)
$12.67B(-0.1%)
Jun 2013
-
$2.96B(-2.5%)
$12.68B(+1.0%)
Mar 2013
-
$3.03B(-15.8%)
$12.56B(+1.7%)
Dec 2012
$12.34B(-2.1%)
$3.60B(+16.8%)
$12.35B(-1.0%)
Sep 2012
-
$3.09B(+8.9%)
$12.48B(-2.1%)
Jun 2012
-
$2.83B(+0.3%)
$12.74B(+1.5%)
Mar 2012
-
$2.82B(-24.3%)
$12.56B(-0.2%)
Dec 2011
$12.61B
$3.73B(+11.3%)
$12.58B(-2.6%)
Sep 2011
-
$3.35B(+26.5%)
$12.92B(+3.0%)
DateAnnualQuarterlyTTM
Jun 2011
-
$2.65B(-7.1%)
$12.54B(+1.4%)
Mar 2011
-
$2.85B(-29.9%)
$12.37B(-1.3%)
Dec 2010
$11.91B(+5.7%)
$4.07B(+36.8%)
$12.53B(+5.4%)
Sep 2010
-
$2.97B(+20.1%)
$11.90B(+1.1%)
Jun 2010
-
$2.47B(-18.1%)
$11.76B(+23.2%)
Mar 2010
-
$3.02B(-11.9%)
$9.55B(+7.5%)
Dec 2009
$11.26B(+1.1%)
$3.43B(+20.7%)
$8.89B(+18.6%)
Sep 2009
-
$2.84B(+996.0%)
$7.49B(+39.1%)
Jun 2009
-
$259.19M(-89.0%)
$5.39B(-5.5%)
Mar 2009
-
$2.36B(+15.9%)
$5.70B(-3.8%)
Dec 2008
$11.14B(+3.1%)
$2.03B(+176.5%)
$5.92B(-15.5%)
Sep 2008
-
$735.66M(+28.9%)
$7.01B(-20.0%)
Jun 2008
-
$570.90M(-77.9%)
$8.77B(-17.3%)
Mar 2008
-
$2.58B(-17.3%)
$10.60B(+1.6%)
Dec 2007
$10.81B(+17.2%)
$3.12B(+25.5%)
$10.43B(+3.5%)
Sep 2007
-
$2.49B(+3.4%)
$10.08B(+2.0%)
Jun 2007
-
$2.41B(-0.2%)
$9.88B(+2.0%)
Mar 2007
-
$2.41B(-12.8%)
$9.68B(+4.6%)
Dec 2006
$9.22B(+6.5%)
$2.77B(+20.7%)
$9.26B(+5.7%)
Sep 2006
-
$2.29B(+3.6%)
$8.76B(+2.1%)
Jun 2006
-
$2.21B(+11.3%)
$8.58B(+0.8%)
Mar 2006
-
$1.99B(-12.4%)
$8.51B(-1.7%)
Dec 2005
$8.66B(+8.4%)
$2.27B(+7.3%)
$8.65B(+0.9%)
Sep 2005
-
$2.11B(-1.4%)
$8.58B(+1.3%)
Jun 2005
-
$2.14B(+0.6%)
$8.46B(+3.1%)
Mar 2005
-
$2.13B(-2.8%)
$8.21B(+2.9%)
Dec 2004
$7.98B(+16.5%)
$2.19B(+9.7%)
$7.98B(+1.0%)
Sep 2004
-
$2.00B(+6.0%)
$7.90B(+24.1%)
Jun 2004
-
$1.89B(-0.9%)
$6.37B(+2.6%)
Mar 2004
-
$1.90B(-10.0%)
$6.20B(+2.0%)
Dec 2003
$6.85B(+7.6%)
$2.11B(+355.8%)
$6.08B(+2.4%)
Sep 2003
-
$463.78M(-73.1%)
$5.94B(-17.8%)
Jun 2003
-
$1.72B(-3.1%)
$7.22B(+1.4%)
Mar 2003
-
$1.78B(-9.7%)
$7.12B(+2.7%)
Dec 2002
$6.37B(-0.2%)
$1.97B(+12.6%)
$6.93B(-1.3%)
Sep 2002
-
$1.75B(+7.8%)
$7.02B(+1.4%)
Jun 2002
-
$1.62B(+1.8%)
$6.92B(+0.6%)
Mar 2002
-
$1.59B(-22.6%)
$6.88B(+1.0%)
Dec 2001
$6.38B(+10.6%)
$2.06B(+24.5%)
$6.81B(+6.4%)
Sep 2001
-
$1.65B(+4.6%)
$6.40B(+4.2%)
Jun 2001
-
$1.58B(+3.7%)
$6.14B(+0.4%)
Mar 2001
-
$1.52B(-7.4%)
$6.12B(+2.2%)
Dec 2000
$5.76B(-9.4%)
$1.65B(+18.1%)
$5.99B(+37.9%)
Sep 2000
-
$1.39B(-10.4%)
$4.34B(+47.3%)
Jun 2000
-
$1.56B(+11.9%)
$2.95B(+53.4%)
Mar 2000
-
$1.39B(+162.0%)
$1.92B(+262.0%)
Dec 1999
$6.36B(+101.8%)
-
-
Jun 1999
-
$530.79M(+9.4%)
$530.79M(+9.4%)
Dec 1998
$3.15B(+4.3%)
-
-
Jun 1998
-
$485.13M
$485.13M
Dec 1997
$3.02B(+3.4%)
-
-
Dec 1996
$2.92B(-4.1%)
-
-
Dec 1995
$3.05B(+58.3%)
-
-
Jun 1994
$1.93B(-32.4%)
-
-
Jun 1993
$2.85B(+15.1%)
-
-
Jun 1992
$2.47B(-27.3%)
-
-
Jun 1991
$3.40B
-
-

FAQ

  • What is GSK plc annual cost of goods sold?
  • What is the all time high annual cost of goods sold for GSK plc?
  • What is GSK plc annual cost of goods sold year-on-year change?
  • What is GSK plc quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for GSK plc?
  • What is GSK plc quarterly cost of goods sold year-on-year change?
  • What is GSK plc TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for GSK plc?
  • What is GSK plc TTM cost of goods sold year-on-year change?

What is GSK plc annual cost of goods sold?

The current annual cost of goods sold of GSK is $12.11B

What is the all time high annual cost of goods sold for GSK plc?

GSK plc all-time high annual cost of goods sold is $14.08B

What is GSK plc annual cost of goods sold year-on-year change?

Over the past year, GSK annual cost of goods sold has changed by +$826.61M (+7.33%)

What is GSK plc quarterly cost of goods sold?

The current quarterly cost of goods sold of GSK is $2.89B

What is the all time high quarterly cost of goods sold for GSK plc?

GSK plc all-time high quarterly cost of goods sold is $4.67B

What is GSK plc quarterly cost of goods sold year-on-year change?

Over the past year, GSK quarterly cost of goods sold has changed by +$266.17M (+10.14%)

What is GSK plc TTM cost of goods sold?

The current TTM cost of goods sold of GSK is $11.60B

What is the all time high TTM cost of goods sold for GSK plc?

GSK plc all-time high TTM cost of goods sold is $14.88B

What is GSK plc TTM cost of goods sold year-on-year change?

Over the past year, GSK TTM cost of goods sold has changed by +$111.46M (+0.97%)
On this page